Vascular Web Logo

SVS  SVS Foundation

 RR12. Familial AAA Is Associated with Increased Postoperative Adverse Events After EVAR

Koen M. van de Luijtgaarden1, Frederico Bastos Goncalves1, Sanne E. Hoeks2, Ellen V. Rouwet1, Danielle Majoor-Krakauer3, Robert J. Stolker2, Hence J. Verhagen1
1Erasmus MC - Department of Vascular Surgery, Rotterdam, Netherlands; 2Erasmus MC - Department of Anesthesiology, Rotterdam, Netherlands; 3Erasmus MC - Department of Clinical Genetics, Rotterdam, Netherlands.

OBJECTIVES: To investigate the risk of postoperative adverse events (PAE) in patients with familial AAA (fAAA) versus sporadic AAA (spAAA).
METHODS: Patients were derived from a prospective database for EVAR. Family history was obtained by written questionnaire (93% response rate). fAAA patients were defined as having ≥1affected 1st-degree relative, and excluding connective tissue disorders. Cardiovascular risk factors, AAA morphology (neck, sac and iliac), and follow-up (FU) information were scored. PAE was defined as a composite of secondary intervention, sac growth (>5mm), and Type I/III endoleak. PAE estimates were obtained from Kaplan-Meier plots and multivariable Cox-regression was used to explore the risk associated with fAAA.
RESULTS: Two hundred seven patients were included (90% men; age 71±8; FU 4.5±3yrs), with 46(22%) classified as fAAA. Patients with fAAA were younger (68 vs. 72 years, p=0.003) and less likely smokers (p=0.056). No difference was observed in AAA morphology. After EVAR, fAAA patients had significantly more PAE (Figure), with a 2-fold increase in risk (adjusted HR 2.0, 95%CI 1.1-3.8). Sac growth was observed in 20% of fAAA vs 9% of spAAA (p=0.005), unrelated to presence of endoleak. There were no further differences in individual components of PAE, nor in overall survival.
CONCLUSIONS: Despite similar morphology, patients with fAAA had more PAE, mainly due to sac growth. Until the underlying cause is identified, patients with fAAA may need closer surveillance.
AUTHOR DISCLOSURES: F. Bastos Goncalves: Nothing to disclose; S. E. Hoeks: Nothing to disclose; D. Majoor-Krakauer: Nothing to disclose; E. V. Rouwet: Nothing to disclose; R. J. Stolker: Nothing to disclose; K. M. van de Luijtgaarden: Lijf & Leven Foundation, Rotterdam, The Netherlands, Research grants; H. J. Verhagen: Nothing to disclose.


Posted April 2013

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320

Follow Us


VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.